Smartphone addiction fuels loneliness and reduces well-being, study finds

How loneliness mediates the link between excessive smartphone use or addiction.

SWOG S1011 trial questions the benefits of extended lymphadenectomy in bladder cancer

The SWOG S1011 randomized phase 3 trial found no significant improvement in disease-free or overall survival but a higher rate of grade 3-4 adverse events

October 3, 2024

FDA Panel Endorses DFMO for Kids’ High-Risk Neuroblastoma in Remission

After wrangling all day over semantics and a potential precedent-setting dataset, an FDA advisory committee voted to recommend approval of eflornithine (difluoromethylornithine; DFMO) maintenance for

October 5, 2023

Biogen nabs FDA approval for its biosimilar of arthritis and Covid-19 drug Actemra

Biogen scored an approval from the FDA for its biosimilar of Roche’s treatment Actemra on Friday, marking the first biosimilar of the drug to be

October 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.